The UAE Ministry of Well being and Prevention (MoHAP) has accepted the emergency use of a highly-effective new remedy for COVID-19, changing into the primary nation on the planet to each licence and allow fast affected person use.
Endorsed by the US Meals and Drug Administration, the brand new remedy, from globally-leading healthcare firm GSK, ‘Sotrovimab (Vir-7831)’ gives the prospect of decreasing hospitalisation for greater than 24 hours and fatalities by as a lot as 85% when administered to sufferers as an early remedy for COVID-19.
The UAE has authorised the emergency use of Sotrovimab, a monoclonal antibody, for the remedy of sufferers aged 12 years or older with gentle to reasonable COVID-19 illness who’re susceptible to development to hospitalisation or loss of life. In pre-clinical research, Sotrovimab has demonstrated effectiveness as a monotherapy in opposition to extensively circulating variants of the illness.
“Such a brand new qualitative achievement wouldn’t have been doable had it not been for the UAE management’s keenness to proactively deal with the pandemic, entice and supply revolutionary medicines that show efficient and environment friendly, and adopting them as remedy protocols,” mentioned AbdulRahman bin Mohamad Al Owais, Minister of Well being and Prevention.
“The brand new medication will enormously contribute to rushing up the restoration of sufferers, decreasing COVID-19-related deaths and hospitalisation interval in intensive care items. It would additionally assist the nation’s efforts being made to conduct COVID-19 exams and administer vaccines, retaining its main place among the many world’s foremost international locations, dealing effectively with the COVID-19 pandemic,” the minister mentioned.
“This achievement is yet one more breakthrough that crowns the painstaking efforts made by our smart management, which spares no effort to harness all capabilities and assets to guard the well being of UAE folks and safeguard the nation’s positive factors achieved over the course of the previous years in any respect ranges,” Al Owais mentioned.
He pressured the significance of partnerships between the UAE well being sector, worldwide analysis establishments and the non-public medical and pharmaceutical sector and counting on science and innovation. This is without doubt one of the nice classes discovered from the COVID-19 pandemic, during which the UAE has confirmed its success in dealing with the biggest well being disaster in trendy historical past.
“The invention of revolutionary options and coverings with a purpose to ship distinct and efficient well being care providers, particularly throughout pandemics, may also help governments face well being crises extra successfully and effectively,” the minister mentioned.
Adopting promising applied sciences
“From the earliest days of the pandemic. the MOHAP technique has centred on embracing promising new applied sciences, together with exams. vaccines and coverings in our efforts to subdue COVID-19”, mentioned Dr Mohamed Salim Al Olama, Below-Secretary at Ministry of Well being and Prevention.
“We now have been happy to accomplice with GSK to make sure that essential components are in place to make sure early entry, from licensing and shipments to coaching and new tips for docs, he mentioned, including that new tips are in place to information docs on applicable use and the way to direct sufferers to the centres the place Sotrovimab shall be out there.
Al Olama emphasised that the UAE has at all times been proactive in approving and registering international revolutionary medicines, based on an revolutionary mechanism developed to judge and approve first-of-its-kind medicines, including that licensing the revolutionary remedy ‘Sotrovimab’ is available in implementation of Regulation No. 8 of 2019 on Medical Merchandise, Pharmacy Career and Pharmaceutical Institutions.